Search

everythinglearnresearchcommunity

for

Search:↓

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

New genetic discoveries may lead to better treatments for alopecia areata.

Significant progress was made in understanding PXE, but effective treatments are still needed.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

Sudden, unusual hair loss may indicate serious underlying health issues.

Genomic research can help improve the quality and production of natural fibers in animals.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.

Certain genes and X chromosome patterns may significantly contribute to the development of hair loss.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

Understanding wool keratin-associated proteins in sheep can help improve wool quality through selective breeding.

Japanese vitiligo patients and their families often have other autoimmune diseases.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Combined arsenic and low oxygen stress alters root growth to help plants absorb nutrients.

Topical immunotherapy can treat alopecia areata, but its effectiveness varies and the exact mechanism is unclear.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Polycystic ovary syndrome increases the risk of diabetes, heart disease, and endometrial cancer, and requires early treatment to manage these risks.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.